BioCentury | Nov 5, 2020
Management Tracks

Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

...CMO.T cell therapy play Adicet Bio Inc. (NASDAQ:ACET) appointed Don Healey as CTO. He joins most recently from KBI Biopharma...
...Inc. Relmada Therapeutics Inc. Adicet Bio Inc. Abeona Therapeutics Inc. Erytech Pharma S.A. SparingVision Inc. Vertex Ventures HC Sangamo Therapeutics Inc. Voyager Therapeutics Inc. KBI Biopharma Inc. CerSci...
BioCentury | May 26, 2014
Company News

KBI Biopharma, Merck deal

...manufacturing services to Merck and to third-party customers. The companies declined to disclose financial terms. KBI Biopharma Inc....
BioCentury | Apr 28, 2014
Emerging Company Profile

Aeglea: Old enzymes, new tricks

...Number of employees: 3 Funds raised: $12 million Investors: Lilly Ventures, Novartis BioVenture Fund and KBI Biopharma Inc....
Items per page:
1 - 3 of 3
BioCentury | Nov 5, 2020
Management Tracks

Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

...CMO.T cell therapy play Adicet Bio Inc. (NASDAQ:ACET) appointed Don Healey as CTO. He joins most recently from KBI Biopharma...
...Inc. Relmada Therapeutics Inc. Adicet Bio Inc. Abeona Therapeutics Inc. Erytech Pharma S.A. SparingVision Inc. Vertex Ventures HC Sangamo Therapeutics Inc. Voyager Therapeutics Inc. KBI Biopharma Inc. CerSci...
BioCentury | May 26, 2014
Company News

KBI Biopharma, Merck deal

...manufacturing services to Merck and to third-party customers. The companies declined to disclose financial terms. KBI Biopharma Inc....
BioCentury | Apr 28, 2014
Emerging Company Profile

Aeglea: Old enzymes, new tricks

...Number of employees: 3 Funds raised: $12 million Investors: Lilly Ventures, Novartis BioVenture Fund and KBI Biopharma Inc....
Items per page:
1 - 3 of 3